Literature DB >> 25702190

Reduction in posterior semicircular canal gain by age in video head impulse testing. Observational study.

Gloria Guerra Jiménez1, Nicolás Pérez Fernández2.   

Abstract

INTRODUCTION: and objectives: In-depth assessment of the vestibulo-ocular reflex with the new video systems available provides information on various previously-unidentified characteristics in patients with peripheral vestibular disorder. The aim of this work is to quantify how often pathological gain (uni- or bilateral) in the posterior semicircular canal (PSC) gain appears in video head-impulse testing (vHIT) with preservation of the gain in the rest of the semicircular canals, and to analyse the relation of this frequency with patient age and/or diagnosis.
METHODS: This was a prospective observational study on adults referred to our unit between June 2012 and February 2014. Age, sex, pathological antecedents, prior history of vestibular pathology, diagnosis and time of evolution of the clinical picture and its characteristics were recorded. Each patient underwent a complete otoneurological examination, including vHIT (Otometrics®). Depending on suspected diagnosis, patients also received cervical vestibular evoked myogenic potential (VEMP) testing, tonal audiometry and speech test, as well as assessment by Neurology and/or nuclear magnetic resonance or computed axial tomography scan imaging study.
RESULTS: In all, 363 patients were assessed; 57 (16%) patients (33 males and 24 females; mean age, 57 ± 15 years) showed pathological PSC gains, 46 (81%) unilateral and 11 (19%) bilateral. Ménière's Disease was the most frequent diagnosis, followed by benign paroxysmal positional vertigo (27%). Patients with unilateral involvement were younger than those with bilateral (55 vs. 68 years; p=0.03). In the patients with bilateral involvement, PSC gain and age were related (-0.7; 0.04) and the gain value was symmetrical in both ears (0.7; p=0.05). The gain in the anterior and horizontal canals tended to decrease with age, but without statistical significance in our sample.
CONCLUSIONS: Of the patients referred for an otoneurological consultation, 16% showed pathological PSC gain (unilateral in 81% and bilateral in 19% of the cases). This gain involvement was attributable to age when the gain was bilateral and symmetrical.
Copyright © 2014 Elsevier España, S.L.U. and Sociedad Española de Otorrinolaringología y Patología Cérvico-Facial. All rights reserved.

Entities:  

Keywords:  Age; Canal semicircular posterior; Edad; Posterior semicircular canal; Test del impulso cefálico; Video head impulse test

Mesh:

Year:  2015        PMID: 25702190     DOI: 10.1016/j.otorri.2014.12.002

Source DB:  PubMed          Journal:  Acta Otorrinolaringol Esp        ISSN: 0001-6519


  4 in total

1.  Assessment of VOR gain function and its test-retest reliability in normal hearing individuals.

Authors:  Shalini Bansal; Sujeet Kumar Sinha
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-03-01       Impact factor: 2.503

2.  Balance in Virtual Reality: Effect of Age and Bilateral Vestibular Loss.

Authors:  Elodie Chiarovano; Wei Wang; Stephen J Rogers; Hamish G MacDougall; Ian S Curthoys; Catherine de Waele
Journal:  Front Neurol       Date:  2017-01-20       Impact factor: 4.003

3.  The Video Head Impulse Test in the acute stage of posterior canal benign paroxysmal positional vertigo.

Authors:  Luigi Califano; Raffaella Iannella; Salvatore Mazzone; Francesca Salafia; Maria Grazia Melillo
Journal:  Acta Otorhinolaryngol Ital       Date:  2021-02       Impact factor: 2.124

4.  Feasibility of Using the Video-Head Impulse Test to Detect the Involved Canal in Benign Paroxysmal Positional Vertigo Presenting With Positional Downbeat Nystagmus.

Authors:  Andrea Castellucci; Pasquale Malara; Salvatore Martellucci; Cecilia Botti; Silvia Delmonte; Silvia Quaglieri; Elisabetta Rebecchi; Enrico Armato; Massimo Ralli; Marco Lucio Manfrin; Angelo Ghidini; Giacinto Asprella Libonati
Journal:  Front Neurol       Date:  2020-10-15       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.